X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (198055) 198055
Newspaper Article (31213) 31213
Newsletter (10790) 10790
Book Chapter (2974) 2974
Magazine Article (2178) 2178
Trade Publication Article (577) 577
Book / eBook (338) 338
Dissertation (292) 292
Transcript (288) 288
Web Resource (262) 262
Book Review (237) 237
Conference Proceeding (94) 94
Report (87) 87
Reference (85) 85
Government Document (64) 64
Publication (28) 28
Paper (15) 15
Streaming Video (14) 14
Journal / eJournal (4) 4
Video Recording (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (137361) 137361
humans (120406) 120406
life sciences & biomedicine (120260) 120260
human immunodeficiency virus--hiv (56650) 56650
female (53593) 53593
animals (51298) 51298
viruses (49235) 49235
male (48688) 48688
hiv (47797) 47797
adult (37691) 37691
health aspects (36453) 36453
infectious diseases (31270) 31270
research (30265) 30265
infections (29890) 29890
virus diseases (29510) 29510
middle aged (28555) 28555
virology (27258) 27258
acquired immune deficiency syndrome--aids (25595) 25595
immunology (23779) 23779
antiviral agents (22032) 22032
research article (21765) 21765
analysis (21376) 21376
mice (20698) 20698
drug therapy (19890) 19890
aids (18706) 18706
medicine (18477) 18477
risk factors (18227) 18227
microbiology (18092) 18092
medical research (17802) 17802
cell line (16409) 16409
care and treatment (16126) 16126
science & technology - other topics (16057) 16057
proteins (15849) 15849
human immunodeficiency virus (15790) 15790
vaccines (15599) 15599
virus replication - drug effects (15485) 15485
multidisciplinary sciences (15374) 15374
antiviral agents - pharmacology (15251) 15251
hepatitis c virus (15132) 15132
hiv infection (14893) 14893
hiv infections - drug therapy (14710) 14710
adolescent (14483) 14483
studies (14378) 14378
hepatitis (14356) 14356
public health (14230) 14230
antiretroviral drugs (13888) 13888
pharmacology & pharmacy (13493) 13493
young adult (12845) 12845
antiviral agents - therapeutic use (12754) 12754
patients (12716) 12716
science (12376) 12376
aged (12313) 12313
aids/hiv (12040) 12040
mortality (11605) 11605
biochemistry & molecular biology (11575) 11575
prevention (11287) 11287
public, environmental & occupational health (10995) 10995
abridged index medicus (10905) 10905
mutation (10220) 10220
treatment outcome (10220) 10220
cancer (9911) 9911
medicine, experimental (9671) 9671
clinical trials (9651) 9651
influenza (9455) 9455
gene expression (9351) 9351
hepatitis c (9314) 9314
oncology (9106) 9106
social sciences (9106) 9106
cells, cultured (9029) 9029
genetic aspects (8991) 8991
medicine, research & experimental (8868) 8868
research & experimental medicine (8850) 8850
drugs (8773) 8773
interferon (8713) 8713
drug resistance (8607) 8607
highly active antiretroviral therapy (8468) 8468
epidemiology (8436) 8436
disease transmission (8404) 8404
cell biology (8277) 8277
hiv-1 - drug effects (8072) 8072
acquired immune deficiency syndrome (7904) 7904
biology (7862) 7862
hiv patients (7788) 7788
infection (7718) 7718
child (7648) 7648
time factors (7597) 7597
viral infections (7512) 7512
usage (7484) 7484
gastroenterology & hepatology (7350) 7350
viral load (7301) 7301
general & internal medicine (7214) 7214
hiv infections - virology (7142) 7142
human papillomavirus (7104) 7104
antigens (7056) 7056
epidemics (7049) 7049
hepatitis b (7049) 7049
medicine & public health (7007) 7007
hiv infections - epidemiology (6940) 6940
physiological aspects (6937) 6937
hepatitis b virus (6907) 6907
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (125) 125
Collection Dvlpm't (Acquisitions) - Vendor file (33) 33
Online Resources - Online (30) 30
UofT at Scarborough - Stacks (20) 20
UofT at Mississauga - Stacks (16) 16
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
New College (Ivey) - Stacks (7) 7
Robarts - Stacks (6) 6
St. Michael's College (John M. Kelly) - 2nd Floor (5) 5
UTL at Downsview - May be requested (5) 5
University College (Laidlaw) - Stacks (5) 5
St. Michael's Hospital - Stacks (3) 3
Gerstein Science - Course Reserves (2) 2
Media Commons - Microtexts (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Pharmacy (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Missing (1) 1
Gerstein Science - Searching (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Law (Bora Laskin) - Theses (1) 1
Media Commons - Audio Visual (1) 1
OISE - Curriculum Resources (1) 1
OISE - Stacks (1) 1
OISE - Theses (1) 1
Richard Charles Lee Canada-Hong Kong - Library use only (1) 1
Scarborough Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Scarborough - Bindery (1) 1
UofT at Scarborough - Circulation Desk (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (243637) 243637
Russian (1670) 1670
Japanese (952) 952
Chinese (950) 950
German (918) 918
French (663) 663
Portuguese (558) 558
Spanish (380) 380
Italian (216) 216
Polish (114) 114
Ukrainian (81) 81
Bulgarian (76) 76
Dutch (53) 53
Korean (53) 53
Norwegian (53) 53
Turkish (34) 34
Swedish (28) 28
Czech (27) 27
Hungarian (25) 25
Afrikaans (24) 24
Danish (20) 20
Romanian (19) 19
Arabic (15) 15
Persian (12) 12
Croatian (9) 9
Serbian (9) 9
Urdu (8) 8
Hebrew (7) 7
Hindi (7) 7
Slovak (6) 6
Finnish (4) 4
Latin (2) 2
Albanian (1) 1
Bosnian (1) 1
Catalan (1) 1
Indonesian (1) 1
Latvian (1) 1
Lithuanian (1) 1
Zulu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Endocrine, metabolic & immune disorders drug targets, ISSN 1871-5303, 2006
Journal
PLoS pathogens, ISSN 1553-7374, 09/2015, Volume 11, Issue 9, pp. e1005142 - e1005142
Pharmacologically-induced activation of replication competent proviruses from latency in the presence of antiretroviral treatment (ART) has been proposed as a... 
Parasitology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Virology | Follow-Up Studies | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Male | RNA, Viral - blood | AIDS Vaccines - therapeutic use | Virus Latency - drug effects | AIDS Vaccines - adverse effects | Anti-HIV Agents - administration & dosage | HIV Infections - immunology | Drug Interactions | HIV-1 - physiology | Lymphocytes - immunology | Protein Processing, Post-Translational - drug effects | HIV-1 - isolation & purification | Adult | Anti-HIV Agents - therapeutic use | Female | Depsipeptides - therapeutic use | RNA, Viral - metabolism | Depsipeptides - adverse effects | Biomarkers - metabolism | Lymphocytes - metabolism | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | Biomarkers - blood | Histones - blood | Acetylation - drug effects | HIV-1 - immunology | Virus Activation - drug effects | Lymphocytes - drug effects | HIV Infections - drug therapy | Histones - metabolism | Infusions, Intravenous | Viral Load - drug effects | Cohort Studies | Depsipeptides - administration & dosage | HIV Infections - metabolism | Index Medicus | Studies | Plasma | HIV | Acquired immune deficiency syndrome | Cytokines | Lymphocytes | Curing | AIDS | Infections | Human immunodeficiency virus | Research | Drug therapy
Journal Article
Cell reports (Cambridge), ISSN 2211-1247, 09/2016, Volume 16, Issue 10, pp. 2576 - 2592
The mechanisms underlying Zika virus (ZIKV)-related microcephaly and other neurodevelopment defects remain poorly understood. Here, we describe the derivation... 
Life Sciences & Biomedicine | Science & Technology | Cell Biology | Neocortex - pathology | Neurons - pathology | Transcription, Genetic - drug effects | Brain - embryology | Neuroglia - ultrastructure | Neuroglia - pathology | Humans | Brain - virology | Centrosome - drug effects | Gene Expression Profiling | Microcephaly - virology | Neural Stem Cells - ultrastructure | Zika Virus Infection - virology | Neural Stem Cells - immunology | Neuroepithelial Cells - immunology | Neuroprotective Agents - pharmacology | Spinal Cord - pathology | Microcephaly - pathology | Neuroepithelial Cells - virology | Nucleosides - pharmacology | Fetus - virology | Cell Death - drug effects | Phosphorylation - drug effects | Neurons - drug effects | Protein-Serine-Threonine Kinases - metabolism | Zika Virus - pathogenicity | Proto-Oncogene Proteins - metabolism | Zika Virus - ultrastructure | Neurons - virology | Virus Replication - drug effects | Neuroepithelial Cells - ultrastructure | Immunity, Innate - drug effects | Zika Virus Infection - pathology | Neural Stem Cells - virology | Zika Virus - physiology | Zika Virus - drug effects | Mitochondria - metabolism | Mitochondria - drug effects | Receptor Protein-Tyrosine Kinases - metabolism | Neural Stem Cells - enzymology | Centrosome - metabolism | Mitosis - drug effects | Brain - pathology | Protein Kinase Inhibitors - pharmacology | Neuroglia - virology | Neuroepithelial Cells - drug effects | Index Medicus | Neurons/pathology | Zika Virus/pathogenicity | Mitochondria/metabolism | Virus Replication/drug effects | Microcephaly/pathology | Neurons/drug effects | Protein-Serine-Threonine Kinases/metabolism | Neural Stem Cells/immunology | Neuroglia/ultrastructure | Neuroepithelial Cells/drug effects | Neuroepithelial Cells/virology | Life Sciences | Brain/pathology | Zika Virus/drug effects | Brain/embryology | Mitochondria/drug effects | Fetus/virology | Neocortex/pathology | Neuroglia/pathology | Cell Death/drug effects | Mitosis/drug effects | Transcription, Genetic/drug effects | Nucleosides/pharmacology | Neural Stem Cells/enzymology | Neural Stem Cells/ultrastructure | Neuroepithelial Cells/ultrastructure | Receptor Protein-Tyrosine Kinases/metabolism | Microcephaly/virology | Proto-Oncogene Proteins/metabolism | Neuroprotective Agents/pharmacology | Zika Virus/ultrastructure | Neuroepithelial Cells/immunology | Brain/virology | Immunity, Innate/drug effects | Spinal Cord/pathology | Zika Virus/physiology | Neuroglia/virology | Microbiology and Parasitology | Zika Virus Infection/pathology | Neurons/virology | Zika Virus Infection/virology | Neural Stem Cells/virology | Centrosome/drug effects | Protein Kinase Inhibitors/pharmacology | Centrosome/metabolism | Phosphorylation/drug effects
Journal Article
Journal of virology, ISSN 0022-538X, 2016, Volume 90, Issue 21, pp. 9683 - 9692
.... While several compounds show promise in vitro and in vivo, these outbreaks underscore the need to accelerate drug discovery... 
Life Sciences & Biomedicine | Science & Technology | Virology | Zika Virus Infection - drug therapy | Acetyltransferases - metabolism | Ebolavirus - metabolism | Chikungunya virus - metabolism | Humans | Eflornithine - pharmacology | Ebolavirus - drug effects | Zika Virus Infection - virology | Disease Outbreaks | RNA Viruses - drug effects | Hemorrhagic Fever, Ebola - virology | Hemorrhagic Fever, Ebola - drug therapy | Spermine - analogs & derivatives | Cell Line | Virus Replication - drug effects | Antiviral Agents - pharmacology | Mice, Inbred C57BL | Chikungunya Fever - drug therapy | Zika Virus - drug effects | Chikungunya Fever - virology | Polyamines - metabolism | Chikungunya virus - drug effects | Animals | Spermine - pharmacology | Mice | Index Medicus | Spermine/analogs & derivatives | Virus Replication/drug effects | Hemorrhagic Fever, Ebola/virology | Life Sciences | Zika Virus/drug effects | Immunology | Chikungunya virus/metabolism | Chikungunya Fever/drug therapy | Zika Virus Infection/drug therapy | Ebolavirus/drug effects | Acetyltransferases/metabolism | Chikungunya virus/drug effects | Eflornithine/pharmacology | Spermine/pharmacology | Polyamines/metabolism | Chikungunya Fever/virology | Hemorrhagic Fever, Ebola/drug therapy | Microbiology and Parasitology | Zika Virus Infection/virology | Ebolavirus/metabolism | Antiviral Agents/pharmacology | RNA Viruses/drug effects
Journal Article
Nature (London), ISSN 1476-4687, 07/2012, Volume 487, Issue 7408, pp. 482 - 485
.... Here we isolated the circulating resting CD4(+) T cells of patients in whom viraemia was fully suppressed by antiretroviral therapy, and directly studied the effect of VOR on this latent reservoir... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Gene Expression Regulation, Viral - drug effects | Humans | Hydroxamic Acids - adverse effects | Histone Deacetylase Inhibitors - administration & dosage | RNA, Viral - blood | Virus Latency - drug effects | Proviruses - drug effects | HIV-1 - growth & development | Proviruses - genetics | Hydroxamic Acids - administration & dosage | Anti-HIV Agents - therapeutic use | CD4-Positive T-Lymphocytes - virology | Hydroxamic Acids - pharmacology | Biomarkers - metabolism | HIV Infections - blood | Risk Assessment | HIV-1 - drug effects | CD4-Positive T-Lymphocytes - cytology | HIV Infections - virology | RNA, Viral - biosynthesis | CD4-Positive T-Lymphocytes - metabolism | Viremia - drug therapy | HIV-1 - genetics | Proviruses - growth & development | Histones - drug effects | Up-Regulation - drug effects | Acetylation - drug effects | Viremia - virology | HIV Infections - drug therapy | Histone Deacetylase Inhibitors - pharmacology | Histones - metabolism | CD4-Positive T-Lymphocytes - drug effects | Histone Deacetylase Inhibitors - adverse effects | Physiological aspects | Antiviral agents | HIV patients | Health aspects | Vorinostat | Antiretroviral drugs | Plasma | Cell culture | Lymphocytes | Human immunodeficiency virus--HIV | Genomes | Drug therapy | Drug dosages | Index Medicus
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 03/2017, Volume 61, Issue 3
As new pathogenic viruses continue to emerge, it is paramount to have intervention strategies that target a common denominator in these pathogens. The fusion... 
Envelope protein | Antiviral | Zika virus | Virus entry | Chikungunya virus | Resistant mutant | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Zika Virus - genetics | Chikungunya virus - genetics | Membrane Glycoproteins - metabolism | Epithelial Cells - drug effects | Humans | Yellow fever virus - growth & development | Semliki forest virus - growth & development | Virus Internalization - drug effects | Endosomes - metabolism | Proto-Oncogene Proteins c-bcl-2 - metabolism | Lysosomes - metabolism | West Nile virus - genetics | Hydrogen-Ion Concentration - drug effects | Endosomes - drug effects | Viral Envelope Proteins - metabolism | Cell Membrane - drug effects | Hepatocytes - drug effects | Membrane Fusion - drug effects | Lysosomes - drug effects | Cell Line | Virus Replication - drug effects | Antiviral Agents - pharmacology | Cricetinae | Gene Expression | Viral Envelope Proteins - genetics | Zika Virus - growth & development | West Nile virus - growth & development | Zika Virus - drug effects | West Nile virus - drug effects | Chikungunya virus - growth & development | Membrane Glycoproteins - genetics | Chikungunya virus - drug effects | Drug Resistance, Viral - genetics | Pyrroles - pharmacology | Yellow fever virus - drug effects | Animals | Semliki forest virus - genetics | Neutral Red - metabolism | Epithelial Cells - virology | Semliki forest virus - drug effects | Hepatocytes - virology | Cell Membrane - virology | Mutation | Proto-Oncogene Proteins c-bcl-2 - genetics | Yellow fever virus - genetics | Index Medicus
Journal Article
Journal of hepatology, ISSN 0168-8278, 2012, Volume 58, Issue 4, pp. 792 - 800
Summary Hepatitis C virus (HCV) infected patients often take multiple co-medications to treat adverse events related to HCV therapy, or to manage other co-morbidities. Drug... 
Gastroenterology and Hepatology | Boceprevir | Hepatitis C virus infection | Telaprevir | Pharmacokinetics | Drug interactions | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Hepatitis C, Chronic - metabolism | Antiviral Agents - pharmacokinetics | Hypnotics and Sedatives - adverse effects | Humans | Hypnotics and Sedatives - administration & dosage | Drug Interactions | Hypoglycemic Agents - administration & dosage | Drug Therapy, Combination | Immunosuppressive Agents - administration & dosage | Cardiovascular Agents - administration & dosage | Anti-Infective Agents - adverse effects | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Opiate Substitution Treatment - adverse effects | Buprenorphine - administration & dosage | Anti-Infective Agents - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Antiviral Agents - adverse effects | Buprenorphine - adverse effects | Antidepressive Agents - administration & dosage | Immunosuppressive Agents - adverse effects | Methadone - administration & dosage | Methadone - adverse effects | Antidepressive Agents - adverse effects | Cardiovascular Agents - adverse effects | Hypoglycemic Agents - adverse effects | Hepatitis C virus | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 02/2016, Volume 113, Issue 6, pp. E782 - E790
Journal Article